)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Cosciens Biopharma (CSCI) investor relations material
Cosciens Biopharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Nov, 2025
Executive summary
Voluntary delisting from Nasdaq completed, with continued listing on TSX and application for OTCQB® Venture Market trading.
Strategic restructuring and zero-based budgeting led to a 59% reduction in operating expenses year-over-year for Q3 2025.
Focus remains on stabilizing core revenue-generating business and improving operational efficiency.
Financial highlights
Q3 2025 net loss was $1.8 million ($0.57 per share), down from $5.8 million ($1.85 per share) in Q3 2024.
Q3 2025 revenue was $1.5 million, a decrease from $1.9 million in Q3 2024, mainly due to lower sales of Avenanthramides, Beta Glucan, Oat Oil, and Macrilen.
Operating expenses for Q3 2025 were $2.9 million, down from $7.3 million in Q3 2024, driven by lower R&D, SG&A, and impairment expenses.
Nine-month 2025 net loss was $8.2 million ($2.59 per share), compared to $8.6 million ($3.58 per share) in the same period of 2024.
Cash and cash equivalents stood at $8.5 million as of September 30, 2025.
Outlook and guidance
Management expects continued cost discipline and operational efficiency from restructuring and zero-based budgeting.
Strategic focus on core business, new category expansion, and potential new markets in food, beverage, dermatology, and pharmaceuticals.
Ongoing evaluation of Macrilen's pediatric indication in the US and Europe, with possible regulatory submissions and partnership opportunities.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cosciens Biopharma earnings date
Q4 202525 Mar, 2026
Next Cosciens Biopharma earnings date
Q4 202525 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cosciens Biopharma Inc is a Chinese biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. The company targets therapeutic areas including oncology, immunology, and central nervous system disorders. It employs proprietary drug discovery platforms and engages in clinical development activities. The company is headquartered in Suzhou, China, and its shares are listed on the SSE STAR Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage